Lisocabtagene maraleucel delivers sustained survival benefits and long-term disease control in relapsed or refractory LBCL.

Findings from a recent phase 3b/4 study of upadacitinib support a treat-to-target strategy for dose escalation or reduction ...

Same-day discharge after complex gynecologic oncology surgery is safe and feasible, with success tied to age, BMI, surgery ...